Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
Top Cited Papers
- 1 April 2002
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 359 (9313) , 1187-1193
- https://doi.org/10.1016/s0140-6736(02)08215-6
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patientsAnnals of the Rheumatic Diseases, 2001
- Enthesitis and ankylosis in spondyloarthropathy: What is the target of the immune response?Annals of the Rheumatic Diseases, 2000
- Infliximab and Methotrexate in the Treatment of Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2Neurology, 1996
- Pathogenesis of spondylarthropathiesArthritis & Rheumatism, 1995
- Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitisArthritis & Rheumatism, 1995
- Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patientsArthritis & Rheumatism, 1994
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984